Clinical Trial Update: A Conversion Study of Immediate Release (IR) and Modified Release (MR) Forms of Topiramate (TPM) [Phase 1]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 1 study comparing immediate-release and modified-release topiramate for epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Topiramate (Topiramate)

Snippet

Sponsor: Supernus Pharmaceuticals, Inc. | Conditions: Epilepsy | Phase 1 | Status: COMPLETED